000 01345 a2200349 4500
005 20250516093423.0
264 0 _c20121107
008 201211s 0 0 eng d
022 _a1872-9096
024 7 _a10.1016/j.antiviral.2012.05.006
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBlanchet, Matthieu
245 0 0 _aSKI-1/S1P inhibition: a promising surrogate to statins to block hepatitis C virus replication.
_h[electronic resource]
260 _bAntiviral research
_cAug 2012
300 _a159-66 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntiviral Agents
_xpharmacology
650 0 4 _aCell Line
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aHepacivirus
_xdrug effects
650 0 4 _aHepatocytes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xpharmacology
650 0 4 _aProprotein Convertases
_xantagonists & inhibitors
650 0 4 _aPyrrolidines
_xpharmacology
650 0 4 _aSerine Endopeptidases
650 0 4 _aVirus Replication
_xdrug effects
700 1 _aSeidah, Nabil G
700 1 _aLabonté, Patrick
773 0 _tAntiviral research
_gvol. 95
_gno. 2
_gp. 159-66
856 4 0 _uhttps://doi.org/10.1016/j.antiviral.2012.05.006
_zAvailable from publisher's website
999 _c21808474
_d21808474